Interventional Radiology Imaging

Should You Consider Vertebral Augmentation for a Worsening Benign Compression Fracture?

·
Should You Consider Vertebral Augmentation for a Worsening Benign Compression Fracture?

An 82-year-old female with known osteoporosis and a T12 vertebral compression fracture (VCF) from a fall three months ago returns to your clinic. Initially, her pain was managed with analgesics and a brace. Today, she reports her mechanical back pain is significantly worse, she feels she is becoming more stooped over, and she gets short of breath walking to the mailbox. Conservative management is clearly failing. You are now faced with deciding the next therapeutic step to alleviate her pain and prevent further functional decline. This clinical workflow article addresses this specific scenario: a benign VCF with worsening pain, deformity, or pulmonary dysfunction. For this presentation, the American College of Radiology (ACR) Appropriateness Criteria rate percutaneous vertebral augmentation as ‘Usually Appropriate’ as an initial treatment.

Who Fits This Clinical Scenario?

This guidance applies to a specific subset of patients with vertebral compression fractures. The key inclusion criteria are a previously diagnosed, presumed benign (typically osteoporotic) VCF where the patient’s condition is actively deteriorating despite initial conservative therapy. This deterioration is defined by one or more of the following:

  • Worsening Pain: The patient’s focal, mechanical back pain is increasing in severity, limiting mobility and quality of life.
  • Progressive Deformity: There is clinical or radiographic evidence of increasing kyphosis (forward curvature of the spine) or loss of vertebral body height.
  • Emerging Pulmonary Dysfunction: The patient is experiencing new or worsening shortness of breath, which can result from decreased thoracic volume due to severe kyphosis.

This workflow is distinct from other VCF scenarios. This article does not apply if:

  • The VCF is newly discovered: A new, symptomatic VCF requires a diagnostic workup first to confirm acuity and rule out malignancy, which is a different ACR variant.
  • The patient is asymptomatic: An incidentally found, stable, and asymptomatic osteoporotic VCF is typically managed with medical therapy for osteoporosis, not intervention.
  • Malignancy is known or suspected: A VCF in a patient with a history of cancer requires a different evaluation to rule out a pathologic fracture, which may involve different treatments like ablation or radiation therapy.

What Diagnoses Are You Working Up in This Scenario?

In this scenario, the initial diagnosis of a benign VCF is already established. The focus shifts from diagnosis to characterizing the reason for clinical failure. The primary considerations are mechanical and structural, reflecting a failure of the fractured vertebra to heal and stabilize.

Progressive Vertebral Collapse: This is the most common cause of worsening symptoms. The fractured vertebral body continues to compress under physiologic load, leading to a greater loss of height. This increased compression exacerbates mechanical pain and worsens spinal alignment, leading to progressive kyphotic deformity. The resulting change in thoracic cage geometry can restrict lung expansion and cause dyspnea.

Vertebral Pseudarthrosis (Nonunion): In some cases, the fracture does not heal, creating a site of painful motion within the vertebral body. This condition, sometimes associated with intravertebral fluid or air on MRI (a “fluid sign” or Kummell’s disease), indicates instability and is a strong predictor that conservative management will fail. The persistent micromotion at the fracture site is a potent pain generator.

Secondary Spinal Canal or Foraminal Stenosis: While less common in benign osteoporotic fractures than in traumatic or malignant ones, severe collapse can cause the posterior wall of the vertebral body to bulge (retropulse) into the spinal canal. This can lead to new or worsening neurologic symptoms, such as radiculopathy or, rarely, myelopathy, which represents a significant escalation in clinical urgency.

Why Is Percutaneous Vertebral Augmentation the Recommended Study for This Presentation?

For a patient with a benign VCF and worsening symptoms, the therapeutic goal is to stabilize the collapsing vertebra to relieve pain and halt progressive deformity. Percutaneous vertebral augmentation, which includes procedures like vertebroplasty and kyphoplasty, directly addresses this mechanical failure. The ACR rates this intervention as ‘Usually Appropriate’ because it provides immediate internal structural support by injecting bone cement into the fractured vertebral body.

This stabilization can lead to rapid and substantial pain relief, improve mobility, and prevent further height loss and kyphosis. By arresting the progressive collapse, it can also mitigate the downstream effects on pulmonary function. The procedure is minimally invasive, often performed on an outpatient basis, which is a significant advantage in this typically frail, elderly patient population.

In contrast, other options are rated lower for this specific context of failed conservative management:

  • Medical Management Only: This is rated ‘May be appropriate’. While essential for treating the underlying osteoporosis, it has likely already proven insufficient to control symptoms or prevent mechanical progression in this scenario. Continuing it alone without intervention fails to address the acute structural problem.
  • Percutaneous Ablation Spine: This is ‘Usually not appropriate’. Ablation therapies (e.g., radiofrequency ablation) are designed to destroy tumor tissue. They have no role in treating a benign, mechanical osteoporotic fracture.

It is important to note that Surgical Consultation is also rated ‘Usually Appropriate’ and should be considered in parallel. While vertebral augmentation is a first-line interventional option, patients with significant neurologic compromise, severe deformity, or instability involving multiple columns may require open surgical fixation. The decision between percutaneous augmentation and open surgery is often made collaboratively between the interventional radiologist or other augmenting provider and a spine surgeon.

What’s Next After Percutaneous Vertebral Augmentation? Downstream Workflow

The clinical pathway following vertebral augmentation depends on the patient’s response to the procedure. The goal is not just immediate pain relief but also long-term stability and prevention of future events.

If the procedure is successful and pain improves: The patient should be transitioned to a physical therapy program to improve core strength and mobility. Critically, aggressive medical management of the underlying osteoporosis must be initiated or optimized to reduce the risk of subsequent fractures at other vertebral levels. This includes pharmacotherapy (e.g., bisphosphonates, denosumab, teriparatide), as well as calcium and vitamin D supplementation.

If pain persists despite a technically successful augmentation: It is crucial to re-evaluate the source of the pain. The differential includes an unrecognized adjacent-level fracture, pain from severe facet arthropathy, sacroiliac joint dysfunction, or discogenic sources. This may prompt further diagnostic imaging, such as an MRI of the spine, to assess for other pain generators that were masked by the severe fracture pain.

If the patient’s deformity or neurologic symptoms are too severe for augmentation: If, during the pre-procedure workup or consultation, it is determined that the patient has significant retropulsion with spinal cord compression or a grossly unstable multi-column injury, the patient should be managed by a spine surgeon. These cases often require more extensive open surgical decompression and stabilization rather than percutaneous cement injection.

Pitfalls to Avoid (and When to Get Help)

Navigating the treatment of worsening VCFs requires careful consideration to avoid common missteps. One major pitfall is failing to confirm the fracture is chronic and not a new, superimposed acute fracture at an adjacent level; advanced imaging like MRI or STIR sequences can be invaluable here. Another common error is delaying intervention in a patient with clear evidence of progressive deformity or pulmonary compromise, as this can lead to irreversible functional decline. Finally, treating the fracture without aggressively managing the underlying osteoporosis is a missed opportunity that almost guarantees future fractures.

When to Escalate: Any new or progressive neurologic deficit—such as leg weakness, numbness, or bowel/bladder dysfunction—is a red flag for spinal cord or nerve root compression. This constitutes a neurosurgical emergency and requires immediate escalation for surgical consultation.

Related ACR Topics and Tools

This article covers a single, specific clinical scenario in depth. For a broader overview of all VCF management variants, from initial imaging to treatment of asymptomatic fractures, please consult our comprehensive parent guide. For additional decision support, the following GigHz resources are available:

Frequently Asked Questions

What is the difference between vertebroplasty and kyphoplasty?

Both are forms of percutaneous vertebral augmentation. In vertebroplasty, bone cement is injected directly into the fractured vertebra under imaging guidance. In kyphoplasty, a balloon is first inserted and inflated within the vertebra to create a cavity and potentially restore some height before the cement is injected. The choice between them depends on fracture characteristics, operator preference, and institutional protocols.

Is vertebral augmentation appropriate for a brand new, acute fracture?

This is a different clinical scenario. For an acute osteoporotic VCF with bone marrow edema, vertebral augmentation is also often considered ‘Usually Appropriate’. However, the scenario discussed in this article is specifically for a known fracture that has failed conservative therapy and is worsening over time, indicating instability or nonunion.

What are the major risks of percutaneous vertebral augmentation?

The primary risk is cement leakage. Cement can leak into the spinal canal, neural foramen, or surrounding soft tissues, which can cause neurologic injury. It can also leak into the venous system, potentially leading to pulmonary embolism. Other risks include infection, bleeding, and rib fractures during the procedure. In experienced hands, the rate of serious complications is low.

How quickly does pain typically improve after vertebral augmentation?

One of the main benefits of vertebral augmentation is the potential for rapid pain relief. Many patients experience a significant reduction in pain within 24 to 48 hours as the cement hardens and stabilizes the fracture. However, the degree and speed of improvement can vary among individuals.

Does vertebral augmentation increase the risk of fractures at other levels?

This is a topic of ongoing debate. Some studies suggest that stiffening one vertebral level with cement may alter spinal biomechanics and increase stress on adjacent vertebrae, potentially raising the risk of subsequent fractures. However, it’s also clear that the underlying osteoporosis is the primary driver of future fractures. This underscores the critical importance of aggressive medical osteoporosis treatment after any VCF, regardless of how it is managed.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026